Literature DB >> 4125641

HL-A 27 and Reiter's syndrome.

J C Woodrow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4125641     DOI: 10.1016/s0140-6736(73)92505-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27).

Authors:  E G Mallas; P Mackintosh; P Asquith; W T Cooke
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

Review 2.  Genetic basis of autoimmunity.

Authors:  Alexander Marson; William J Housley; David A Hafler
Journal:  J Clin Invest       Date:  2015-06-01       Impact factor: 14.808

3.  Selective inhibition of lymphocyte responsiveness to phytohaemagglutinin in patients with Reiter's syndrome.

Authors:  I Scher; A Ahmed; D M Strong; R Wistar
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

4.  Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis.

Authors:  D Nordstrom; O Lindy; Y T Konttinen; A Lauhio; T Sorsa; C Friman; T Pettersson; S Santavirta
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

5.  Postdysenteric Reiter's syndrome.

Authors:  D H Lehman
Journal:  West J Med       Date:  1977-05

6.  Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia.

Authors:  C G van Bohemen; F C Grumet; H C Zanen
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

7.  Uveitis, vitreous humour, and klebsiella. II. Cross-reactivity studies with radioimmunoassay.

Authors:  J Welsh; H Avakian; A Ebringer
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

8.  HLA antigens and uveitis.

Authors:  S Ohno; S J Kimura; G R O'Connor; D H Char
Journal:  Br J Ophthalmol       Date:  1977-01       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.